Latest filing published 23 Dec 2022 for Black Diamond Therapeutics, Inc., €24k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Fang Ni: trading record in brief
Fang Ni appears in our data through filings on Black Diamond Therapeutics, Inc. shares, published by SEC (Form 4). Between 29 June 2022 and 22 December 2022, the trades on record add up to 3 filings.
Every open-market trade on record is a purchase: 3 purchases worth €127k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
In size, the median ticket on the buying side is €44k. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
Most recently, on 23 December 2022, the filings show an open-market purchase worth €44k in Black Diamond Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Fang Ni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$1.288529.3% of flowCommon StockSEC:0001415889-22-012966:0Canonical exit: 21 Mar 2023 (T+90)
- 25,000 shares@ US$2.44070.058% mcap100.0% of flowCommon StockSEC:0001415889-22-007099:0Canonical exit: 27 Sept 2022 (T+90)
2 of 2 declarations
